Related Experiment Video
Updated: Dec 12, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
A Pediatric Infectious Disease Perspective on COVID-19
Ellen R Wald1, Kathryn M Schmit1, Daniele Y Gusland1
1Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Coronavirus disease 2019 (COVID-19) in children is typically mild, but key questions remain about transmission. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shows lower severity in pediatric populations compared to other respiratory viruses.
Area of Science:
- Pediatrics
- Infectious Diseases
- Epidemiology
Background:
- Coronavirus disease 2019 (COVID-19) presents unique challenges in pediatric populations.
- Understanding pediatric COVID-19 is crucial for public health strategies and adult disease impact.
- Comparison with common respiratory viruses like RSV and influenza is essential.
Purpose of the Study:
- To review the clinical and epidemiologic characteristics of COVID-19 in children and neonates.
- To contrast pediatric COVID-19 features with other common respiratory viruses.
- To address unanswered questions regarding pediatric COVID-19 attack rates and transmission roles.
Main Methods:
- Literature review of clinical and epidemiologic data on pediatric COVID-19.
- Comparative analysis of COVID-19 with other respiratory viral infections in children.
- Examination of disease severity across different pediatric subgroups and pregnant cohorts.
Main Results:
- Most pediatric COVID-19 infections are mild.
- Distinctive clinical features for diagnosis without laboratory testing are absent.
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrates lower morbidity and mortality in children compared to RSV and influenza.
- COVID-19 appears less severe in children with cancer and in pregnant individuals.
- Intrauterine transmission is documented but rare.
- Individuals with modulated immune systems may experience less severe disease.
Conclusions:
- Pediatric COVID-19 is generally mild, but transmission dynamics require further investigation.
- SARS-CoV-2 poses a lesser threat to children than influenza or RSV.
- Pregnant individuals and immunocompromised children may have comparable or less severe outcomes.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...

